Hitting cancer early: AstraZeneca’s bid to outmaneuver rivals

July 6, 2018 admin Business News Comments Off on Hitting cancer early: AstraZeneca’s bid to outmaneuver rivals

LONDON (Reuters) – AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News